TCW Multisector Credit Income ETF MUSE 深 沪
等待开盘 09-13 09:30:00 美东时间
50.87
+0.025
+0.05%
华盛通- 最 高50.87
- 今 开50.845
- 成交量 10股
- 最 低 50.87
- 昨 收 50.845
- 总市值 5087.00万
- 52周最高 50.87
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 46.55
- 委 比 0.00%
- 总股本 100.00万
- 历史最高 50.87
- 量 比 0
- 振 幅 0.00%
- 历史最低 46.55
- 每 手 1
- 风险率 0.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多「穿户外」的人，正在「杀死」户外
作者：王利 编辑：王小坤 同一片土地，同一个市场，两家企业交出了相反的年中成绩单。 一边是探路者的“形势严峻、内部阵痛”，归母净利润同比暴跌74...
09-12 08:00
Vibrant Broadband Transforms Middle Mile Infrastructure with Ribbon
Achieves tenfold bandwidth increase, streamlined deployment, and increased network visibility PLANO, Texas, Aug. 18, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global ...
08-18 20:00
全球首款！光伏领域最新成果惊艳亮相2025上海别墅展！
在全球能源转型和可持续发展的大背景下，建筑作为碳排放的重要载体，其绿色转型已不仅是技术命题，更关乎人类对 “栖居” 本质的重新审视。在 “双碳” 目标与建筑美学...
08-11 17:32
Alterity Faces ASX Scrutiny Over Timing of Market-Sensitive MRI Study Announcement
Alterity Therapeutics Limited (‘ATH'): ASX Aware LetterASX refers to the following:A.ATH's announcement titled ‘Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study'
08-04 19:59
Alterity Therapeutics Says Peer-Reviewed Publication In Annals Of Clinical And Translational Neurology Highlights Use Of MSA Atrophy Index Developed To Diagnose And Track Disease Progression In Multiple System Atrophy
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an
07-24 19:28
Alterity Therapeutics Presents MSA Research At 2025 International MSA Congress; ATH434 Phase 2 Data Shows Clinically Meaningful Efficacy On Multiple Clinical Endpoints
– ATH434 Phase 2 data demonstrated clinically meaningful efficacy on multiple clinical endpoints –– MSA Atrophy Index (MSAai) enhances MSA diagnosis and monitoring –– bioMUSE Study shows higher α- synuclein concentration
05-12 19:39
361度2025年首季开门红：科技赋能增长，多维布局驱动品牌全球化跃升
4月14日，国内领先体育运动品牌361度(01361.HK)公布了2025年第一季度运营成果，数据显示，公司主品牌零售额同比增长10%–15%，童装业务零售额同...
04-15 09:07
Heathrow AOC, Collins Aerospace extend deal for smoother passenger flow
Collins Aerospace, an RTX business (NYSE:RTX), has secured a six-year renewal pact with Heathrow Airline Operators' Committee (AOC) to continue providing its ARINC cMUSE solution across all four Londo...
04-09 15:28
Why Is Pharma Giant Roche Stock Trading Lower On Wednesday?
Roche's MUSETTE trial found no additional benefit of high-dose Ocrevus over the 600 mg IV dose, reaffirming its efficacy and safety for relapsing multiple sclerosis.
04-03 03:12
TG Therapeutics rises after trial setback for high dose version of Roche’s MS drug
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Wednesday that a Phase 3 trial for a high-dose version of its multiple sclerosis therapy Ocrevus (ocrelizumab) failed in a Phase 3 trial, sending the shares...
04-03 00:15
